series-c-plus
Stage
3
Investors
About
Ablynx is a biopharmaceutical company that discovers and develops nanobodies, which are proprietary therapeutic proteins aimed at treating serious diseases including inflammation, hematology, immuno-oncology, oncology, and respiratory conditions.
Explore Ablynx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.